Trevor has a broad, global experience with over 25 years in growth-oriented medical technology markets. Trevor’s 25+ year career in medical technology has included roles in product development, marketing, management consulting and venture capital investing. Trevor has been instrumental in working with M. H. Carnegie & Co. to build their healthcare portfolio. He has been directly involved in sourcing, negotiated and managing investments in high-growth medical device companies including Cardiac Dimensions (percutaneous mitral valve repair), Serene Medical (aesthetic medical devices), and Simplify Medical (cervical spinal disc replacement). In 2015 Trevor also served as Interim CEO of Cardiac Dimensions.
Trevor was a General Partner at Frazier Healthcare Ventures, a leading healthcare venture capital and private equity investment firm with over $2.0 billion under management. He co-led the Frazier medical device team and became known as an active and well-regarded investor with particular depth in medical devices. Prior to Frazier Healthcare, Trevor was a Senior Consultant at The Wilkerson Group. Trained as a Biomedical Engineer with an electrical focus, Trevor held product development and product marketing roles at Telectronics Pacing Systems and Ventritex, both in the Cardiac Rhythm Management market.
Trevor serves on the board of the Center for Infectious Disease Research, the largest independent, non-profit research institute in the US focused on vaccines, therapeutics, and diagnostics for diseases of the developing world. He was the board chair from 2012 to 2014. He is also on the board of ElectroCore Medical, Serene Medical, Simplify Medical, and is a board observer at Cardiac Dimensions.
Trevor graduated from the University of Southern Queensland, Australia with a Bachelor of Engineering (Biomedical), and the Massachusetts Institute of Technology with a Masters of Science in Management (Sloan School).